A multicenter clinical trial comparing once and twice-daily subcutaneous enoxaparin and intravenous heparin in the treatment of acute deep vein thrombosis (DVT)

被引：0
|
作者：
Moia, M [1 ]
机构：
[1] Maggiore Hosp, IRCCS, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
来源：
THROMBOSIS RESEARCH | 1998年 / 91卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
26
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [21] Rivaroxaban has predictable pharmacokinetics (PK) and pharmacodynamics (PD) when given once or twice daily for the treatment of acute, proximal deep vein thrombosis (DVT).
    Mueck, Wolfgang
    Agnelli, Giancarlo
    Buller, Harry
    BLOOD, 2007, 110 (11) : 556A - 557A
  • [22] Once-Daily Enoxaparin in The Outpatient Setting Versus Unfractionated Heparin in Hospital for the Treatment of Symptomatic Deep-Vein Thrombosis
    Beng H. Chong
    Tim A. Brighton
    Ross I. Baker
    Peter Thurlow
    Choon H. Lee
    Journal of Thrombosis and Thrombolysis, 2005, 19 : 173 - 181
  • [23] Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis
    Chong, BH
    Brighton, TA
    Baker, RI
    Thurlow, P
    Lee, CH
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2005, 19 (03) : 173 - 181
  • [24] SUBCUTANEOUS VS INTRAVENOUS HEPARIN IN THE TREATMENT OF DEEP VENOUS THROMBOSIS - A RANDOMIZED CLINICAL-TRIAL
    PINI, M
    PATTACINI, C
    QUINTAVALLA, R
    POLI, T
    MEGHA, A
    TAGLIAFERRI, A
    MANOTTI, C
    DETTORI, AG
    THROMBOSIS AND HAEMOSTASIS, 1990, 64 (02) : 222 - 226
  • [25] SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN VERSUS SUBCUTANEOUS UNFRACTIONATED HEPARIN IN THE TREATMENT OF DEEP-VEIN THROMBOSIS - A POLISH MULTICENTER TRIAL
    LOPACIUK, S
    MEISSNER, AJ
    FILIPECKI, S
    ZAWILSKA, K
    SOWIER, J
    CIESIELSKI, L
    BIELAWIEC, M
    GLOWINSKI, S
    CZESTOCHOWSKA, E
    TOKARCZYK, J
    VOSS, A
    WOLCZYNSKI, Z
    KLOCZKO, J
    CZEKALSKI, P
    ZIEMSKI, JM
    HAJDUK, B
    RADOMYSKI, A
    TOKARZ, A
    PSUJA, P
    LEWANDOWSKI, K
    SZYMCZAK, P
    MISIAK, B
    KARON, J
    JUDKIEWICZ, L
    THROMBOSIS AND HAEMOSTASIS, 1992, 68 (01) : 14 - 18
  • [26] INITIAL DOSING OF SUBCUTANEOUS CA++ HEPARIN IN THE TREATMENT OF PROXIMAL DEEP-VEIN THROMBOSIS (DVT)
    WHITE, RH
    DASCHBACH, MM
    KECK, K
    CLINICAL RESEARCH, 1988, 36 (03): : A422 - A422
  • [27] The effect of intraoperative subcutaneous heparin on prophylaxy of deep vein thrombosis (DVT) in surgical treatment of acetabular fractures
    Taleb, Hassan
    Ghodratizadeh, Mitra
    Hassanzadeh, Soma
    MEDICINA BALEAR, 2022, 37 (03): : 80 - 84
  • [28] A MULTINATIONAL, MULTICENTRE, RANDOMIZED, OPEN-LABEL, PARALLEL GROUP STUDY ON THE EFFICACY AND SAFETY OF ONCE DAILY BEMIPARIN COMPARED TO TWICE DAILY ENOXAPARIN IN THE TREATMENT OF ACUTE DEEP VEIN THROMBOSIS
    Schellong, S. M.
    Martinez-Gonzalez, J.
    Suchkov, I. A.
    Falciani, M.
    Kaltwasser, M. T.
    THROMBOSIS RESEARCH, 2016, 141 : S5 - S5
  • [29] Comparison of a once daily versus a twice daily subcutaneous Nadroparin calcium regimens in the treatment of deep vein thrombosis. On behalf of the FRAXODI group.
    Charbonnier, BA
    Fiessinger, JN
    Sixma, JJ
    Wenzel, E
    dAzemar, P
    Sagnard, L
    CIRCULATION, 1996, 94 (08) : 4343 - 4343
  • [30] Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin
    Partsch, H
    Kechavarz, B
    Mostbeck, A
    Kohn, H
    Lipp, C
    JOURNAL OF VASCULAR SURGERY, 1996, 24 (05) : 774 - 782
12345